ASPN - NYSE

Aspen Aerogels, Inc.

ASPN·NYSE

$5.90

-5.1%

IndustrialsConstruction

Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$488.98M

EPS-4.7400

P/E Ratio-1.24

Earnings Date08/06/2026

406.68M

Assets

-55%

3Y-37.0%

5Y+317.0%

10Y+202.0%

171.16M

Total Liabilities

-39%

3Y-13.0%

5Y+479.0%

10Y+796.0%

235.52M

Total Equity

-62%

3Y-47.0%

5Y+247.0%

10Y+104.0%

Aspen Aerogels, Inc. Funding & Solvency Profile

ASPN · NYSE

Current Assets

Cash & Cash Equivalents156.86M

Net Receivables35.27M

Inventory38.25M

Other Current Assets11.68M

Total Current Assets242 M

Non-Current Assets

Property, Plant & Equipment122.55M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets42.08M

Total Non-Current Assets165 M

Total Assets

406.68M

Financial Health Analysis

Current Ratio

3.90x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.73x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

180 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

60% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Aspen Aerogels, Inc. Balance Sheet

ASPN • NYSE

Aspen Aerogels, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2010	Dec 2009
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	156.9M	220.9M	139.7M	281.3M	76.6M	16.5M	3.6M	3.3M	10.7M	18.1M	32.8M	49.7M	1.6M	1.3M	26.8M	27.5M
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4M	0.0
Cash & Short-Term Investments	156.9M	220.9M	139.7M	281.3M	76.6M	16.5M	3.6M	3.3M	10.7M	18.1M	32.8M	49.7M	1.6M	1.3M	30.8M	27.5M
Net Receivables	35.3M	109.1M	70M	57.4M	20.4M	15.7M	32.3M	25.6M	26.8M	17.5M	20.6M	17.9M	18.8M	14.2M	10.2M	4.2M
Accounts Receivables	35.3M	109.1M	70M	57.4M	20.4M	15.7M	32.3M	25.6M	26.8M	17.5M	20.6M	17.9M	18.8M	14.2M	10.2M	4.2M
Inventory	38.2M	47.6M	39.2M	22.5M	12M	13.1M	8.8M	7.3M	8.9M	12.9M	6.5M	4.9M	6.9M	6.3M	2.3M	1.6M
Prepaids	0.0	0.0	0.0	0.0	3.2M	1.8M	1.1M	1M	1.3M	1.7M	1.7M	836K	791K	426K	419K	354K
Other Current Assets	11.7M	31.9M	17.4M	8.5M	0.0	0.0	1.1M	1M	1.3M	1.7M	0.0	836K	0.0	0.0	124K	100K
Total Current Assets	242.1M	409.4M	266.3M	369.7M	112.2M	47.1M	45.8M	37.3M	47.7M	50.2M	61.6M	73.4M	28.1M	22.3M	43.8M	33.8M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	122.5M	480.1M	434.4M	271.2M	69.3M	50.2M	57.6M	61.7M	76.1M	84.4M	78.3M	71.5M	62M	72.6M	42.6M	29.8M
Other Non-Current Assets	42.1M	5.6M	2.3M	2.5M	1.5M	84K	84K	73K	86K	89K	105K	175K	331K	390K	2.4M	1.2M
Total Non-Current Assets	164.6M	485.7M	436.7M	273.7M	70.8M	50.3M	57.7M	61.8M	76.2M	84.5M	78.4M	71.7M	62.4M	73M	45M	30.9M
Total Assets	406.7M	895.1M	703M	643.4M	183M	97.4M	103.5M	99M	123.8M	134.7M	140.1M	145M	90.4M	95.3M	88.8M	64.7M
LIABILITIES
CURRENT LIABILITIES
Total Payables	13.2M	44.4M	51.1M	54.7M	17.4M	5.4M	12.6M	12.4M	10.7M	13.1M	10.7M	14.2M	7.1M	9.1M	5.6M	2.9M
Accounts Payable	13.2M	44.4M	51.1M	54.7M	17.4M	5.4M	12.6M	12.4M	10.7M	13.1M	10.7M	14.2M	7.1M	9.1M	5.6M	2.9M
Accrued Expenses	0.0	17.1M	5.9M	3.5M	1.8M	1.3M	6.5M	2.8M	4.6M	2.8M	4.2M	737K	3.9M	1.5M	6M	791K
Short Term Debt	34.6M	23.8M	0.0	0.0	0.0	1.6M	3.1M	4.2M	3.8M	0.0	0.0	0.0	18.7M	1.3M	247K	262K
Capital Lease Obligations (Current)	0.0	3.3M	1.9M	2.4M	2.2M	1M	1M	0.0	0.0	35K	67K	76K	75K	43K	20K	15K
Deferred Revenue	1.3M	2.2M	2.3M	5.8M	6M	2M	5.6M	2.6M	1.3M	1M	681K	292K	595K	1.2M	447K	630K
Other Current Liabilities	13M	19.4M	16.9M	12.5M	9M	2.6M	1.6M	1.1M	1.2M	1.2M	1.8M	4.9M	1.1M	8M	6.8M	7.4M
Total Current Liabilities	62M	110.1M	78.1M	78.9M	36.6M	13.9M	30.4M	23.1M	21.6M	18.1M	17.4M	20.2M	31.5M	21.1M	19.1M	12M
NON-CURRENT LIABILITIES
Long Term Debt	79.8M	137.1M	115M	103.6M	0.0	2.1M	0.0	0.0	0.0	0.0	0.0	0.0	119.6M	108.6M	7.8M	247K
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	5M	9.6M	9.8M	4.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	434K	-9.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	9.8M	5.7M	1.3M	971K	151K	1M	1.1M	0.0	119.9M	46.3M
Total Non-Current Liabilities	109.1M	170.3M	136.9M	117M	18M	15.6M	14.1M	5.7M	1.3M	975K	191K	1.1M	120.9M	108.7M	127.8M	46.6M
Capital Lease Obligations	29.3M	36.5M	23.8M	15.8M	15.2M	4.6M	5.3M	0.0	0.0	39K	107K	165K	240K	122K	72K	66K
Total Liabilities	171.2M	280.4M	215M	196M	54.5M	29.6M	44.5M	28.8M	22.9M	19.1M	17.6M	21.3M	152.4M	129.8M	146.9M	58.6M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1M	145M	0.0	86.3M	0.0	0.0
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26K	26K
Additional Paid-In Capital	0.0	1.3B	1.2B	1.1B	673.5M	575.8M	545.1M	541.8M	538.1M	533.1M	528M	522.8M	270.8M	164.4M	138M	192.4M
Retained Earnings	-1B	-660.2M	-673.6M	-627.8M	-545.1M	-508M	-486.2M	-471.6M	-437.1M	-417.5M	-405.5M	-399.1M	-332.8M	-285.1M	-196.2M	-186.3M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-92.7M	-82.5M	-72M	-62.2M	0.0	-43.2M	-36.6M	8K	0.0
Other Total Stockholders' Equity	1.3B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6M	109.8M	0.0
Total Stockholders' Equity	235.5M	614.7M	488.1M	447.4M	128.4M	67.9M	59M	70.3M	100.9M	115.6M	122.5M	123.7M	-62M	-34.5M	-58.1M	6.2M
Total Equity	235.5M	614.7M	488.1M	447.4M	128.4M	67.9M	59M	70.3M	100.9M	115.6M	122.5M	123.7M	-62M	-34.5M	-58.1M	6.2M
SUMMARY
Total Liabilities & Equity	406.7M	895.1M	703M	643.4M	183M	97.4M	103.5M	99M	123.8M	134.7M	140.1M	145M	90.4M	95.3M	88.8M	64.7M
Total Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4M	0.0
Total Debt	143.7M	197.4M	138.8M	119.4M	15.2M	8.3M	8.5M	4.2M	3.8M	39K	107K	165K	138.6M	110.1M	8.1M	575K
Net Debt	-13.2M	-23.5M	-951K	-161.9M	-61.3M	-8.2M	4.8M	854K	-6.9M	-18M	-32.7M	-49.6M	137M	108.7M	-18.7M	-26.9M
Shares Outstanding	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491	82,360,491

SEC Filings

ASPN - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 18, 2026	May 12, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 21, 2026	April 21, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 27, 2026	May 13, 2026	2026	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	March 23, 2026	December 31, 2025	2025	View Filing
10-K 10-K 2025 FY FY	March 13, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 25, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 18, 2025	December 16, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing

Showing 1 to 10 of 223 filings

Related Guides

Blog Categories

Continue your ASPN research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.